By Professor Anne Margaret Keogh

Journal articles

Keogh AM; Mayer E; Benza R; Corris P; Dartevelle P; Frost A; Kim N; Lang M; Pepke-Zaba J; Sandoval J, 2009, 'Interventional and surgical modalities of treatment in pulmonary hypertension', Journal of the American College of Cardiology, 54, pp. 67 - 77

Axisa C; Jansz P; Granger E; Hayward C; Keogh A; Kotlyar E; Macdonald P; Spratt P, 2009, 'Left Ventricular Assist Devices—Patient discharge and distance education within New South Wales community locations', Heart, Lung and Circulation, 18, pp. 83 - 83, http://dx.doi.org/10.1016/j.hlc.2008.11.046

Foo D; Walker BD; Kuchar D; Thorburn CW; Tay A; Hayward CS; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz PC, 2009, 'Left ventricular mechanical assist devices and cardiac device interactions: an observational case series', Pace - Pacing and Clinical Electrophysiology, 32, pp. 879 - 887, http://dx.doi.org/10.1111/j.1540-8159.2009.02403.x

Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS, 2009, 'Multi-centre Crossover Comparison of Carvedilol, Metoprolol Succinate and Bisoprolol in Patients with Chronic Heart Failure', Heart, Lung and Circulation, 18, pp. S181 - S181, http://dx.doi.org/10.1016/j.hlc.2009.05.411

Hayward CS; Yeoh T; Benson VL; Keogh AM; Macdonald PS; Feneley MP; Fatkin D, 2009, 'Non-invasive Assessment of Preload Recruitable Stroke Work Relations in Preclinical Cardiomyopathy', Heart, Lung and Circulation, 18, pp. S77 - S78, http://dx.doi.org/10.1016/j.hlc.2009.05.173

Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Axisa C; Hayward CS, 2009, 'Older Age is Associated with Suboptimal Outcomes on Continuous-Flow Left Ventricular Assist Devices', Heart, Lung and Circulation, 18, pp. S182 - S182, http://dx.doi.org/10.1016/j.hlc.2009.05.414

Prichard R; Juul M; Gazibarich G; Walker R; Salamonsen R; Kotlyar E; Keogh AM; Macdonald PS; Hayward CS; Woodard J; Ayre P, 2009, 'Six-Minute Walk Distance Predicts VO2max in Patients Supported with Continuous Flow Left Ventricular Assist Devices', Heart, Lung and Circulation, 18, pp. S188 - S189, http://dx.doi.org/10.1016/j.hlc.2009.05.428

Iwasenko J; Scott GM; Rawlinson WD; Keogh AM; Mitchell D; Chou S, 2009, 'Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D', Journal of Medical Virology, 81, pp. 507 - 510

Jabbour A; Hayward CS; Keogh AM; Kotlyar E; McCrohon J; England JF; Amor R; Liu X; Graham RM; Macdonald PS, 2009, 'The Safety and Efficacy of Recombinant Human Neuregulin-1 in Patients with Stable Chronic Heart Failure', Heart, Lung and Circulation, 18, pp. S192 - S192, http://dx.doi.org/10.1016/j.hlc.2009.05.436

Watson A; Jansz P; Granger E; Farnsworth A; Axisa C; Kotlyar E; Keogh A; Haryward C; Macdonald P; Spratt P, 2008, 'CONTINUOUS-FLOW VERSUS PULSATILE-FLOW LVADS USED AS A BRIDGE-TO-TRANSPLANTATION', Transplantation, 86, pp. 270 - 270, http://dx.doi.org/10.1097/01.tp.0000331997.03853.fd

Otton J; Hayward C; Keogh A; Kotlyar E; Macdonald P; Malouf M; Glanville AR, 2008, 'EVEROLIMUS-ASSOCIATED PNEUMONITIS', Transplantation, 86, pp. 542 - 542, http://dx.doi.org/10.1097/01.tp.0000331140.87844.72

Axisa C; Jansz P; Granger E; Hayward C; Keogh A; Kotlyar E; Tay A; Macdonald P; Spratt P, 2008, 'VENTRICULAR FIBRILLATION IN THE PATIENT IMPLANTED WITH A CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE – CASE REPORT', Transplantation, 86, pp. 531 - 531, http://dx.doi.org/10.1097/01.tp.0000331253.01375.2e

Segovia J; Gerosa G; Almenar L; Livi U; Viganò M; Arizón JM; Yonan N; Di Salvo TG; Renlund DG; Kobashigawa JA; Aaronson K; Ahualli L; Arpesella G; Crespo MG; Davis SF; Butler J; Dengler T; Egan J; Eisen HJ; Haddad H; Davies R; Keogh AM; Lehmkuhl HB; Hummel M; Hetzer R; Miller LW; Modry D; Burton J; Mullen GM; Pisani B; Murday AJ; Ross H; Alonso-Pulpon L; Perrone S; Zucker MJ, 2008, 'Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation', Clinical Transplantation, 22, pp. 809 - 814, http://dx.doi.org/10.1111/j.1399-0012.2008.00887.x

Zuckermann A; Arizon J; Wang S-S; MacCherini M; Vermes E; Bara C; Ross H; Laufer G; Lehmkuhl H; Keogh AM; Sips C, 2008, '161: Impact of De Novo Everolimus-Based Immunosuppression on Wound Healing and Tissue Regeneration in Heart Transplantation', The Journal of Heart and Lung Transplantation, 27, pp. S118 - S118, http://dx.doi.org/10.1016/j.healun.2007.11.168

Bara C; Wang S-S; Zuckermann A; Ross H; Frigerio M; Eisen HJ; Laufer G; Cotrufo M; Keogh AM, 2008, '17: De Novo Concentration-Controlled Everolimus Is Associated with a Decreased Incidence of CMV Infection in Cardiac Transplant Recipients', The Journal of Heart and Lung Transplantation, 27, pp. S66 - S66, http://dx.doi.org/10.1016/j.healun.2007.11.021

Watson A; Jansz P; Granger E; Farnsworth A; Axisa C; Kotlyer E; Keogh A; Hayward C; Macdonald P; Spratt P, 2008, 'A Single-Hospital Experience with 29 Continuous-Flow Left Ventricular Assist Devices', Heart, Lung and Circulation, 17, pp. S154 - S154, http://dx.doi.org/10.1016/j.hlc.2008.05.366

Keogh A; Hardcastle P; Ali SF, 2008, 'Anterior cervical fusion using the IntExt combined cage/plate.', J Orthop Surg (Hong Kong), 16, pp. 3 - 8, http://dx.doi.org/10.1177/230949900801600102

Feldman JP; Keogh A, 2008, 'ARIES-3: LONG-TERM AMBRISENTAN THERAPY IN PATIENTS WITH PULMONARY HYPERTENSION WHO PREVIOUSLY DISCONTINUED BOSENTAN OR SITAXSENTAN DUE TO LIVER FUNCTION ABNORMALITIES', Chest, 134, pp. 160P - 160P, http://dx.doi.org/10.1378/chest.134.4_meetingabstracts.p160003

Lee PN; Coates C; Walker R; Macdonald P; Keogh A; Kotlyar E; Hayward C, 2008, 'Arterial Pressure Waveform Analysis in Systolic Heart Failure: A Cross-Sectional Study', Heart, Lung and Circulation, 17, pp. S141 - S141, http://dx.doi.org/10.1016/j.hlc.2008.05.334

Strange G; Keogh AM; Williams T; Wlodarczyk J; McNeil K; Gabbay E, 2008, 'Bosentan therapy in patients with pulmonary arterial hypertension: The relationship between improvements in 6 minute walk distance and quality of life', Respirology, 13, pp. 674 - 682, http://dx.doi.org/10.1111/j.1440-1843.2008.01326.x

Keogh AM; Jabbour A; Hayward CS; Macdonald PS, 2008, 'Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension', Vascular Health and Risk Management, 4, pp. 1111 - 1113

Watson A; Jansz P; Granger E; Farnsworth A; Axisa C; Kotlyer E; Keogh A; Hayward C; Macdonald P; Spratt P, 2008, 'Continuous-Flow vs. Pulsatile-Flow LVADs Used as a Bridge-to-Transplantation', Heart, Lung and Circulation, 17, pp. S155 - S155, http://dx.doi.org/10.1016/j.hlc.2008.05.369

Tay A; Walker B; Kuchar D; Thorburn C; Fansworth A; Spratt P; Jansz P; Granger E; Macdonald P; Hayward C; Kotlyar E; Keogh A; Subbiah R, 2008, 'Late Onset High-grade Atrioventricular Block Post-Cardiac Transplantion: A Single Centre Experience', Heart, Lung and Circulation, 17, pp. S113 - S114, http://dx.doi.org/10.1016/j.hlc.2008.05.272

Kassam I; Henderson D; Keogh A; Macdonald P; Muller D; Hayward C, 2008, 'Results of Percutaneous intervention in patients with Transplant Coronary Artery Disease: A Retrospective Analysis', Heart, Lung and Circulation, 17, pp. S180 - S180, http://dx.doi.org/10.1016/j.hlc.2008.05.427

Hummel M; Yonan N; Ross H; Miller LW; Sechaud R; Balez S; Koelle EU; Gerosa G; Aaronson K; Ahualli L; Almenar L; Arizon JM; Arpesella G; Crespo MG; David SF; Butler J; Dengler T; Egan J; Eisen HJ; Haddad J; Davies R; Keogh AM; Kobashigawa J; Lehmkuhl HB; Hetzer R; Livi U; Modry D; Burton J; Mullen GM; Pisani B; Murday AJ; Renlund DG; Segovia J; Alonso-Pulpon L; Perrone S; Vigano M; Zucker MJ, 2007, 'Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients', Clinical Transplantation, 21, pp. 18 - 23, http://dx.doi.org/10.1111/j.1399-0012.2006.00569.x

Keogh A; Wang SS; Zuckermann A; Ross H; Frigerio M; Eisen H; Bara C; Laufer G; Cotrufo M; Lena S; Sips C, 2007, '396: Everolimus in de novo heart transplant recipients: Six month data on cyclosporine reduction and impact on renal function', The Journal of Heart and Lung Transplantation, 26, pp. S202 - S202, http://dx.doi.org/10.1016/j.healun.2006.11.417

Hunt J; Bedánová H; Starling RC; Rabágo G; Banner NR; Kobashigawa J; Keogh A; Kormos R; Mehra M; Wahlers T; Noeldeke J, 2007, '398: Premature termination of a prospective, open label, randomized, multicenter study of sirolimus to replace calcineurin inhibitors (CNI) in a standard care regimen of CNI, MMF and corticosteroids early after heart transplantation', The Journal of Heart and Lung Transplantation, 26, pp. S203 - S203, http://dx.doi.org/10.1016/j.healun.2006.11.419

Jabbour A; Keogh AM; Hayward CS; Macdonald PS, 2007, 'Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation', European Journal of Heart Failure, 9, pp. 674 - 677

Zuckermann A; Wang ST; Keogh AM; Ross H; Frigerio M; Eisen H; Bara C; Laufer G; Cotrufo M, 2007, 'Everolimus and cyclosporine reduction in de novo heart transplant recipients transplants: Impact on wound healing', Transplant International, 20, pp. 95 - 95

Keogh AM; Wang SS; Zuckermann A; Ross H; Frigerio M; Eisen M, 2007, 'Everolimus in de novo heart transplant recipients: Six month data on cyclosporine reduction and impact on renal function', Journal of Heart and Lung Transplantation, 26, pp. S202 - S202

Benza R; Park M; Keogh AM; Girgis R, 2007, 'Management of pulmonary arterial hypertension with a focus on combination therapies', Journal of Heart and Lung Transplantation, 26, pp. 437 - 446

Kirk EP; Sunde M; Costa M; Rankin S; Wolstein O; Castro ML; Butler T; Hyun C; Guo G; Otway R; Mackay J; Waddell L; Cole A; Hayward CS; Keogh AM; Macdonald PS; Griffiths L; Fatkin D; Sholler G; Zorn AM; Feneley MP; Winlaw D; Harvey RP; Butler , 2007, 'Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiornyopathy', American Journal of Human Genetics, 81, pp. 280 - 291

Hunt JE; Bedanova H; Starling R; Rabago G; Banner N; Kobashigawa J; Keogh AM; Kormos R; Mehra M; Wahlers T; Noeldeke J, 2007, 'Premature termination of a prospective, open label, randomized, multicenter study of sirolimus to replace calcineurin inhibitors (CNI) in a standard care regimen of CNI, MMF and corticosteroids early after heart transplantation', Journal of Heart and Lung Transplantation, 26, pp. S203 - S203

Keogh AM; McNeil K; Wlodarczyk J; Gabbay E; Williams T, 2007, 'Quality of life in pulmonary arterial hypertension: Improvement and maintenance with bosentan', Journal of Heart and Lung Transplantation, 26, pp. 181 - 187

Jabbour A; Hayward C; Keogh A; Kotlyar E; Liu X; Zhou MD; Li XY; McCrohon J; Graham RM; Macdonald P, 2007, 'Recombinant Human Neuregulin-1 (rhNRG-1) Improves Cardiac Output in Patients with Stable Chronic Heart Failure', Heart, Lung and Circulation, 16, pp. S13 - S13, http://dx.doi.org/10.1016/j.hlc.2007.06.034

Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS, 2007, 'Safety and Efficacy of Transition From Subcuaneous Treprostinil to Oral Sildenafil in Patients with Pulmonary Arterial Hypertension', Journal of Heart and Lung Transplantation, 26 (11), pp. 1079 - 1083

Keogh AM; Kotlyar E; Macdonald PS; Hayward CS; Corrigan C; Pidoux A; Brown KM; Williams T; Gabbay E; McNeil K, 2007, 'Sequential combination therapy in pulmonary arterial hypertension (PAH)', Journal of Heart and Lung Transplantation, 26, pp. S186 - S186

Keogh AM; Richardson M; Ruygrok P; Macdonald PS; Schneider L; O Driscoll G; Galbraith A, 2007, 'Sirolimus vs azathiopine from the time of heart transplantation: 65 month followup for vascular (MACE) and malignant events', Journal of Heart and Lung Transplantation, 26, pp. S231 - S232

Benza R; Mehta S; Keogh AM; Lawrence E; Oudiz R; Barst R, 2007, 'Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan', Journal of Heart and Lung Transplantation, 26, pp. 63 - 69

Zahir H; Keogh AM; Akhlaghi F, 2006, 'Erratum: Apparent clearance of sirolimus in heart transplant recipients: Impact of primary diagnosis and serum lipids (Therapeutic Drug Monitoring (2006) 28, 5 (614-622))', Therapeutic Drug Monitoring, 28, pp. 817, http://dx.doi.org/10.1097/01.ftd.0000255011.75863.15

Krum H; Jelinek MV; Stewart S; Sindone A; Atherton JJ; Hawkes AL; Amerena J; Beltrame J; Burrell L; Campbell D; Davidson P; DePasquale C; Doughty R; Esmore D; Feneley M; Galbraith A; Gilbert R; Goble A; Hare D; Horowitz J; Kalman J; Kaye D; Keogh A; Larbalestier R; Leitch J; McDonald P; Marwick T; McGuire M; Meyers D; Mottram P; Pollock C; Walsh W, 2006, 'Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006', Medical Journal of Australia, 185, pp. 549 - 556, http://dx.doi.org/10.5694/j.1326-5377.2006.tb00690.x

Keogh A, 2006, 'Guest editor's introduction', Transplantation, 82, http://dx.doi.org/10.1097/01.tp.0000243149.91035.10

O'Loughlin AJC; Keogh A; Muller DWM, 2006, 'Insertion of a Fenestrated Amplatzer Atrial Septostomy Device for Severe Pulmonary Hypertension', Heart Lung and Circulation, 15, pp. 275 - 277, http://dx.doi.org/10.1016/j.hlc.2006.02.002

Girgis RE; Keogh AM; Benza RL; Naeije R, 2006, '55', The Journal of Heart and Lung Transplantation, 25, pp. S62 - S63, http://dx.doi.org/10.1016/j.healun.2005.11.057

Benza RL; Keogh AM; Ivy DD; Sandoval J; Barst RJ, 2006, '94', The Journal of Heart and Lung Transplantation, 25, pp. S76 - S76, http://dx.doi.org/10.1016/j.healun.2005.11.099

Zahir H; Keogh AM; Akhlaghi F, 2006, 'Apparent clearance of sirolimus in heart transplant recipients: Impact of primary diagnosis and serum lipids', Therapeutic Drug Monitoring, 28, pp. 614 - 622

Kotlyar E; Sy R; Keogh AM; Kermeen F; Macdonald PS; Hayward CS; McNeil K; Celermajer DS, 2006, 'Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease', Cardiology in the Young, 16, pp. 268 - 274

Chua R; Keogh AM; Byth K; O Loughlin A, 2006, 'Comparsion and validation of three measures of quality of life in patients with pulmonary hypertension', Internal Medicine Journal, 36, pp. 705 - 710

Ray J; Keogh AM; McLachlan AJ, 2006, 'Decision support tool to individualise cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclospoine C2 monitoring', Journal of Heart and Lung Transplantation, 25, pp. 1223 - 1229

Wlodarczyk J; Cleland L; Keogh AM; McNeil K; Perl K; Weintraub R; Williams TJ, 2006, 'Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharing', Pharmacoeconomics, 24, pp. 903 - 915

Back to profile page